The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Challenges in enrolling to metastatic castration-resistant prostate cancer (mCRPC) studies that require androgen receptor splice variant (AR-V) positivity.
 
Michael Thomas Schweizer
No Relationships to Disclose
 
Kathleen Haugk
No Relationships to Disclose
 
Heather H. Cheng
Research Funding - Astellas Medivation; Inovio Pharmaceuticals; Sanofi
 
Jessica L Maes
No Relationships to Disclose
 
Ruth F Dumpit
No Relationships to Disclose
 
Peter Nelson
Consulting or Advisory Role - Astellas Medivation; Janssen; Roche
 
Robert B. Montgomery
Research Funding - ESSA; Janssen Oncology; Medivation/Astellas; Tokai Pharmaceuticals
 
Stephen R Plymate
No Relationships to Disclose
 
Evan Y. Yu
Consulting or Advisory Role - Agensys; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen; Medivation; Merck; Sanofi; Seagen; Tokai Pharmaceuticals; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); GTx (Inst); Lilly/ImClone; Oncogenex (Inst)
Travel, Accommodations, Expenses - Exelixis; Lilly